The Cost-Effectiveness of Tibial Metaphyseal Cones in Revision Total Knee Arthroplasty

J Arthroplasty. 2022 Jun;37(6S):S50-S55. doi: 10.1016/j.arth.2021.12.026. Epub 2022 Feb 17.

Abstract

Background: The purpose of this study is to evaluate the cost-effectiveness of tibial cones in revision total knee arthroplasty.

Methods: A Markov model was used for cost-effectiveness analysis. The average cone price was obtained from Orthopedic Network News. The average cone aseptic loosening rate was determined by literature review. Hospitalization costs and baseline re-revision rates were calculated using the PearlDiver Database.

Results: The maximum cost-effective cone price varied from $3514 at age 40 to $648 at age 90, compared to the current average selling price of $4201. Cones became cost-effective with baseline aseptic loosening rates of 0.89% annually at age 40 to 4.38% annually at age 90, compared to the current average baseline loosening rate of 0.76% annually.

Conclusion: For the average patient, tibial cones are not cost-effective, but may become so at lower prices, in younger patients, or in patients at substantially increased risk of aseptic loosening.

Keywords: Markov analysis; cost-effectiveness; economics; metaphyseal cones; revision total knee arthroplasty.

MeSH terms

  • Adult
  • Aged, 80 and over
  • Arthroplasty, Replacement, Knee* / adverse effects
  • Cost-Benefit Analysis
  • Humans
  • Knee Joint / surgery
  • Knee Prosthesis* / adverse effects
  • Prosthesis Design
  • Reoperation
  • Retrospective Studies